Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;32(5):864-74.
doi: 10.1016/j.neurobiolaging.2009.04.017. Epub 2009 May 30.

Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats

Affiliations

Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats

Milos Cekic et al. Neurobiol Aging. 2011 May.

Abstract

Administration of the neurosteroid progesterone (PROG) has been shown to be beneficial in a number of brain injury models and in two recent clinical trials. Given widespread vitamin D deficiency and increasing traumatic brain injuries (TBIs) in the elderly, we investigated the interaction of vitamin D deficiency and PROG with cortical contusion injury in aged rats. Vitamin D deficient (VitD-deficient) animals showed elevated inflammatory proteins (TNFα, IL-1β, IL-6, NFκB p65) in the brain even without injury. VitD-deficient rats with TBI, whether given PROG or vehicle, showed increased inflammation and greater open-field behavioral deficits compared to VitD-normal animals. Although PROG was beneficial in injured VitD-normal animals, in VitD-deficient subjects neurosteroid treatment conferred no improvement over vehicle. A supplemental dose of 1,25-dihydroxyvitamin D(3) (VDH) given with the first PROG treatment dramatically improved results in VitD-deficient rats, but treatment with VDH alone did not. Our results suggest that VitD-deficiency can increase baseline brain inflammation, exacerbate the effects of TBI, and attenuate the benefits of PROG treatment; these effects may be reversed if the deficiency is corrected.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Uninjured (SHAM) deficient animals show elevated levels of inflammatory cytokine proteins (light) compared to nutritionally normal animals (dark). Values are normalized to normal uninjured animals (vertical axis = 1). Asterisks denote a significant t-test with p < 0.05. Western blot images refer to the cytokine located in the graph above, and β-actin images indicate loading controls. Nrm: normal; Def: vitamin D deficient.
Fig. 2
Fig. 2
(A) Injured deficient animals treated with vehicle show elevated levels of inflammatory proteins at 24 h (dark grey) and 72 h (light grey) after injury compared to nutritionally normal animals. (B) Injured deficient animals treated with PROG also show increased inflammation at 24 and 72 h compared to normal animals. All protein results are normalized to the values for nutritionally normal animals at the same time-point, i.e., all normal values (not shown) are at value = 1 on the vertical axis. Asterisks denote a significant t-test with p < 0.05. Western blot images refer to the cytokine located in the graph above, and β-actin images indicate loading controls. Nrm: normal; Def: vitamin D deficient.
Fig. 3
Fig. 3
Levels of individual inflammatory cytokine proteins, cleaved caspase-3, and p53 in deficient injured animals under different treatment conditions at 24 h (dark grey) and 72 h (light grey) after injury. Results are normalized to the vehicle (VH) group within each time-point (vertical axis value = 1). Asterisks (*) denote post hoc p < 0.05 significance relative to VH, and (#) denotes p < 0.05 relative to PROG. The major treatment effect significantly different from vehicle in most cases is only D + PROG, suggesting a reversal of the injurious effect of deficiency. Western blot images refer to the treatment group in the graph above, and β-actin images indicate loading controls.
Fig. 4
Fig. 4
Open-field activity results for normal (dark grey) and deficient (light grey) animals showing a beneficial effect with combined D + PROG treatment in all cases. All results are normalized to the SHAM group for each nutritional condition. Asterisks (*) denote post hoc p < 0.05 vs. VH (normal) and hash marks (#) denote p < 0.05 vs. VH (deficient).

Similar articles

Cited by

References

    1. Asakura H, Aoshima K, Suga Y, Yamazaki M, Morishita E, Saito M, Miyamoto K, Nakao S. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models. Thromb Haemost. 2001;85:287–290. - PubMed
    1. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs—a brief overview. Mol Cell Biochem. 2003;253:247–254. - PubMed
    1. Barrera D, Avila E, Hernandez G, Halhali A, Biruete B, Larrea F, Diaz L. Estradiol and progesterone synthesis in human placenta is stimulated by calcitriol. J Steroid Biochem Mol Biol. 2007;103:529–532. - PubMed
    1. Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood–brain barrier. Mol Pharmacol. 2004;66:413–419. - PubMed
    1. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci. 2001;21:98–108. - PMC - PubMed

Publication types